Home Search
xolair - search results
If you're not happy with the results, please do another search
Insurance Change Jeopardizes 12-Year-Old’s Xolair Treatment
Maddie's access to this supervised care is now threatened by a policy change from Blue Cross Blue Shield of Illinois.
A Conversation About Mia, a 9-Year-Old Undergoing Xolair Therapy for Food Allergies
Ilana Dubrovsky discusses the progress of her nine-year-old daughter, who is currently undergoing therapy.
Omalizumab (Xolair) Is Superior to Oral Immunotherapy in Multi-Food Allergy Treatment
Research finds food allergic patients have better outcomes with omalizumab than oral immunotherapy.
Six Facts to Know About Xolair for Food Allergies
This week, the FDA approved Xolair for the treatment of food allergies. Here's a slideshow featuring six important facts to know about this new...
FDA Approves Xolair for Children and Adults With One or More Food Allergies
A significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placebo.
FDA Grants Xolair Priority Review for Children and Adults with Food Allergies
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure.
Study: Omalizumab (Xolair) May Help Treat Idiopathic Anaphylaxis
Small study finds drug may be effective in treating IA.
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Newsletter Archive
Catch up on past newsletters.
From 23 Allergies to Food Freedom: Isaiah’s Journey with TIP
His journey highlights the challenges he overcame and offers valuable advice for other teens considering TIP treatment.
